Spring Creek Capital’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

Spring Creek Capital’s Portfolio CTV.WS Stock Details CTV.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,500	Closed	-$13K	–	120
2022 Q1	$13K	Hold	12,500	–	–	﹤0.01%	754
2021 Q4	$14K	Buy	+12,500	New	+$15.6K	﹤0.01%	659

Other funds holding CTV.WS

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

IAC

ION Acquisition Corp Herzliya, Israel $5.63M AUM 38.71% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Ulysses Management New York $802M AUM 5.35% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $200M AUM 23.6% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Spring Creek Capital's CTV.WS Position: Q2 2022 in Review

Spring Creek Capital sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q2 2022, closing a stake of 12,500 shares — an estimated $13K sold.

Spring Creek Capital first reported a position in CTV.WS in Q4 2021 and held it in 2 quarters. The position peaked at $14K in Q4 2021. 23 funds tracked by Wall St. Rank hold CTV.WS as of Q2 2022.

Spring Creek Capital reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q2 2022 after selling out during the quarter.
Spring Creek Capital sold 12,500 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q2 2022, an estimated $13K.
Spring Creek Capital first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 2 quarters.
Spring Creek Capital's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $14K in Q4 2021.
23 funds tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q2 2022.

Based on Spring Creek Capital's 13F filing for Q2 2022.